Bicuculline-Induced Brain Activation in Mice Detected by
Functional Magnetic Resonance Imaging
Thomas Mueggler, Diana Baumann, Martin Rausch, and Markus Rudin
*
Dynamic measurements of local changes in relative cerebral
blood volume (CBV
rel
) during a pharmacological stimulation
paradigm were performed in mice. Using magnetite nanopar-
ticles as an intravascular contrast agent, high-resolution CBV
rel
maps were obtained. Intravenous administration of the GABA
A
antagonist bicuculline prompted increases in local CBV
rel
as
assessed by MRI with a high spatial resolution of 0.2 0.2 mm
2
and a temporal resolution of 21 s. Signal changes occurred
20 –30 s after the onset of drug infusion in the somatosensory
and motor cortex, followed by other cortical and subcortical
structures. The magnitudes of the CBV
rel
increases were 18%
4%, 46% 14%, and 67% 7%, as compared to prestimulation
values for the cortex, and 9% 3%, 25% 4%, and 36% 7%
for the caudate putamen for bicuculline doses of 0.6, 1.25,
and 1.5 mg/kg, respectively. On-line monitoring of trans-
cutaneous carbon dioxide tension PtcCO
2
reflecting arte-
rial PaCO
2
did not show any alteration during the stimulation
paradigm. One of five of the mice receiving the highest bicu-
culline dose, and three of seven receiving the intermediate dose
displayed a different cortical response pattern. After a CBV
rel
increase of 40% lasting for approximately 1 min, significant
CBV
rel
reductions by 80% have been observed. Subcortical
structures did not display this behavior. The present study sug-
gests that this noninvasive approach of functional MRI (fMRI)
can be applied to study drug-induced brain activation by central
nervous system (CNS) drugs in mice under normal and patho-
logical situations. Magn Reson Med 46:292–298, 2001.
© 2001 Wiley-Liss, Inc.
Key words: functional magnetic resonance imaging; relative
cerebral blood volume; bicuculline; pharmacological stimula-
tion; mouse; iron-oxide nanoparticles; transcutaneous blood
gas monitoring
Genetic engineering and transgenic technology have led to
advances in the generation of animal models that develop
aspects of various brain pathologies, and have emphasized
the need to develop accurate methods when phenotyping
these animals. Such models would benefit from the devel-
opment of noninvasive methods to study disease progres-
sion while allowing for a correlation with behavioral stud-
ies. The purpose of the present study was to assess the
feasibility of functional magnetic resonance imaging
(fMRI) in mice by monitoring changes in local relative
cerebral blood volume (CBV
rel
) during pharmacological
stimulation under controlled physiological conditions,
and hence to assess the potential of pharmacological fMRI
as a noninvasive method to characterize transgenic and
knock-out mice models.
fMRI has proven its utility for the noninvasive mapping
of brain function with high temporal and spatial resolu-
tion. Depending on the method applied, image contrast in
fMRI is determined either by the oxygenation state of
hemoglobin (BOLD) (1) or by changes in cerebral hemody-
namics, i.e., cerebral blood flow (CBF) (2,3) and CBV (4).
Using superparamagnetic iron-oxide nanoparticles as a
blood-pool contrast agent, a local CBV
rel
increase is re-
flected by an increase in the amount of magnetite nano-
particles in the activated tissue and, correspondingly, by a
decrease in the signal intensities in T
2
-weighted images.
High-resolution CBV
rel
maps can be derived from the sig-
nal attenuation once the tracer has reached a steady-state
blood concentration. Applying this CBV
rel
-fMRI method,
activation in the rat sensory cortex caused by electrical
stimulation of the forepaw was demonstrated (5,6). Hemo-
dynamic changes associated with a pharmacological stim-
ulation paradigm have been demonstrated in rats, and
could be used to study drugs at the specific receptor level.
Systemic infusion of the GABA
A
antagonist bicuculline
led to an alteration in neuronal activity in cortical and
subcortical brain structures. Dose-dependent CBV
rel
in-
creases have been measured in various brain structures
(e.g., the cortex, thalamus, and caudate putamen) in the
rat (7).
It is well known that physiological parameters, such as
body temperature and blood gases, will affect CBV values.
Mandeville et al. (6) reported CBV
rel
increases on the order
of 50% in rats during hypercarbia by increasing arterial
CO
2
tension (PaCO
2
) from 25–55 mmHg. Although reports
on the quantitative relationship between changes in CBV
rel
and PaCO
2
differ considerably, it is obvious that control
and continuous monitoring of blood CO
2
and blood oxy-
genation are critical for detecting small alterations of ce-
rebrovascular parameters in the mouse. Although larger
animals can sustain frequent blood samplings, noninva-
sive monitoring of blood gases has been found to be essen-
tial when studying mice in order to minimize blood loss,
which might affect cerebral hemodynamics. Transcutane-
ous blood gas monitoring is a noninvasive method used
clinically (8 –10), and it has also been applied to MRI
measurement of the rat to monitor alterations in transcu-
taneous CO
2
tension (PtcCO
2
) under different respiration
conditions and hypercarbia (11).
The purpose of this study was to demonstrate the
feasibility of fMRI in anesthetized, ventilated mice.
Pharmacological stimulation with the GABA
A
antago-
nist bicuculline, which has been well characterized in
fMRI studies in rats, was used as the stimulation para-
digm. PtcCO
2
was measured using an on-line transcuta-
neous blood gas monitoring system with a Severing-
haus-type CO
2
electrode.
Core Technologies Area, Novartis Pharma Ltd, Basel, Switzerland.
*Correspondence to: Markus Rudin, Ph.D., CTA/Analytical and Imaging Sci-
ences Unit, WSJ-386.2.02, Novartis Pharma AG, CH-4002 Basel, Switzer-
land. E-mail: markus-1.rudin@pharma.novartis.com
Received 20 September 2000; revised 25 January 2001; accepted
12 February 2001.
Magnetic Resonance in Medicine 46:292–298 (2001)
© 2001 Wiley-Liss, Inc. 292